Perspectives on IP strategy, patent valuation, structured invention, and the evolving landscape of intellectual property from the team at ipCapital Group.
Let's discuss how ipCapital Group can help you build, protect, and monetize your intellectual property portfolio.
Talk with Our Team
Senator Patrick Leahy discusses the America Invents Act, PTAB review, first to file, and the patent policy changes he still wants to see.
In this episode, John explores the types of businesses that may or may not need intellectual property (IP), like patents and trade secrets. Learn whether your business needs IP to protect its business model, or if filing patents will just increase expenses. The topics in this episode include: Business Brand and Personal Brand Business Risk …
Peloton’s on-demand fitness patents were invalidated at the PTAB. What the Echelon win means for patent value and enforcement risk.
Written by John Cronin CEO and Chairman of ipCapital Group, inc. This article is also available as a PDF One way to innovate is to ensure that the megatrends are evaluated in your innovation processes. Megatrends, by definition, have shown they are customer-driven needs! Of course, there could be differences of opinions as to what …
In today’s episode, John discusses the process to create a power intellectual property tool: provisional patent applications. Provisional applications can be leveraged in many and offer strategic advantages to businesses and inventors. The topics in today’s episode include: 1 – What is a Provisional Application? 2 – Types of Provisional Applications 3 – Strategic Uses …
NFT patents are still scarce while blockchain filings soar. Why early, broad NFT patent filings could stake out valuable IP territory.
Patent valuation puts a number on your IP so you can license proactively, attract investors, use patents as loan collateral, and raise capital.
The DABUS cases test whether AI can be a patent inventor or copyright author. How the EPO, USPTO, South Africa, and Australia have ruled.
COVID-era patent lawsuits hit Moderna, Regeneron, and Pfizer. What biotech patent disputes teach about licensing and enforcement risk.
Sanctions cut Russia off from PCT payments while the Kremlin legalizes patent infringement. What it means for global patent protection.
The Matter smart home standard is royalty free. Why connectivity patents may lose value and how IP holders should rethink their portfolios.
John Cronin and Nancy Edwards Cronin are named again to the IAM Strategy 300 Global Leaders list of top IP strategists worldwide.